Milk bioactive peptides: Their interest for cardiovascular diseases and metabolic syndrome prevention;Les peptides bioactifs du lait et leur intéret dans la prévention des maladies cardiovasculaires et du syndrome métabolique

Medecine des Maladies Metaboliques

Volumn 8, Issue 5, 2014, Pages 495-499

  Leonil J ^a  

^a UMR1253   (France)

Author keywords

Bioactive peptides; Biological activity; Cardiovascular diseases; Metabolic syndrome; Milk; Milk proteins; Prevention

Indexed keywords

FREE RADICAL; MILK BIOACTIVE PEPTIDE; MILK PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; FOOD INTAKE; METABOLIC SYNDROME X;

EID: 84926161248     PISSN: 19572557     EISSN: 22148477     Source Type: Journal    
DOI: 10.1016/s1957-2557(14)70863-6     Document Type: Article

References (19)

1. Maubois JL, Léonil J. Peptides du lait a activité biologique. Lait 1989;69:245-69.
2. Gagnaire V, Mollé D, Herrouin M, Léonil J. Peptides identified during Emmental cheese ripening: origin and proteolytic systems involved. J Agri Food Chem 2001;49:4402-13.
3. Boutrou R, Gaudichon C, Dupont D, et al. Sequential release of milk protein-derived bioactive peptides in the jejunum in healthy humans. Am J Clin Nutr 2013;97:1314-23.
4. Foltz M, Meynen EE, Bianco V, et al. Angiotensin converting enzyme inhibitory peptides from a lactotripeptides-enriched milk beverage are absorbed intact into the circulation. J Nutr 2007;137:953-8.
5. Crichton GE, Bryan J, Buckley J, Murphy KJ. Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev 2011;12:e190-201.
6. McGrane MM, Essery E, Obbagy J, et al. Dairy consumption, blood pressure, and risk of hypertension: an evidence-based review of recent literature. Curr Cardiovasc Risk Rep 2011;5:287-98.
7. Ralston RA, Lee JH, Truby H, et al. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J Hum Hypertens 2012;26:3-13.
8. Pfeuffer M, Schrezenmeir J. Milk and the metabolic syndrome. Obes Rev 2007;8:109-18.
9. Alonso A, Zozaya C, Vázquez Z, et al. The effect of low-fat versus whole-fat dairy product intake on blood pressure and weight in young normotensive adults. J Hum Nutr Diet 2009;22:336-42.
10. Bucher HC, Cook RJ, Guyatt GH, et al. Effects of dietary calcium supplementation on blood pressure: A meta-analysis of randomized controlled trials. JAMA 1996;275:1016-22.
11. Boelsma E, Kloek J. Lactotripeptides and antihypertensive effects: a critical review. Br J Nutr 2009;101:776-86.
12. Jauhiainen T, Niittynen L, Ore?c? M, et al. Effects of long-term intake of lactotripeptides on cardiovascular risk factors in hypertensive subjects. Eur J Clin Nutr 2012;66:843-9.
13. Rutherfurd KJ, Gill HS. Peptides affecting coagulation. Br J Nutr 2000;84(Suppl.1):S99-102.
14. Hall WL, Millward DJ, Long SJ, Morgan LM. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003;89:239-48.
15. Froetschel MA, Azain MJ, Edwards GL, et al. Opioid and cholecystokinin antagonists alleviate gastric inhibition of food intake by premeal loads of casein in meal-fed rats. J Nutr 2001;131:3270-6.
16. Aziz A, Anderson GH. Exendin-4, a GLP-1 receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats. J Nutr 2003;133:2326-30.
17. Marsset-Baglieri A, Fromentin G, Airinei G, et al. Milk protein fractions moderately extend the duration of satiety compared with carbohydrates independently of their digestive kinetics in overweight subjects. Br J Nutr 2014;112:557-64.
18. Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (anses). Efficacité et innocuité des régimes sans gluten et sans caséine proposés a des enfants présentant des troubles envahissants du développement (autisme et syndromes apparentés). Rapport, avril 2009. www.anses.fr/sites/default/ files/documents/NUT-Ra-Autisme.pdf
19. Kullisaar T, Songisepp E, Mikelsaar M, et al. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br J Nutr 2003;90:449-56.